Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|March 22, 2012
[A five-year follow-up of one hundred and thirty-six patients of hepatitis C]Lan-hui She, Chao-shuang Lin, Qing-xian Cai, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|January 29, 2010
[Study on rhGM-CSF as adjuvant in revaccination among adults of non-and hyporesponders to hepatitis B vaccine]He-Xiang Chen, Xiang-Yang Wang, Shun-Qin Wang, et al.
International Journal of Clinical and Experimental Medicine|June 24, 2014
Expansion of myeloid-derived suppressor cells from peripheral blood decreases after 4-week antiviral treatment in patients with chronic hepatitis CYing Liu, Lan-Hui She, Xiang-Yang Wang, et al.
Biomed Research International|February 25, 2017
Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin TreatmentGeng-Lin Zhang, You-Ming Chen, Ting Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2013
High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBVGeng-Lin Zhang, Dong-Ying Xie, Yi-Nong Ye, et al.
International Journal of Medical Sciences|October 24, 2013
Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort studyYu-Bao Zheng, Zhan Lian Huang, Zhe Bin Wu, et al.
Canadian Journal of Gastroenterology & Hepatology|June 5, 2018
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with RelapseWen-Xiong Xu, Qian Zhang, Xiang Zhu, et al.
Hepatology International|July 24, 2015
A Novel prognostic scoring system to predict 3-month mortality risk in patients with acute-on-chronic liver failure in hepatitis B: a retrospective cohort studyYu-Bao Zheng, Shi-Bin Xie, Dong-Ying Xie, et al.
Plos One|July 31, 2012
Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failureYu-Bao Zheng, Xiao-Hong Zhang, Zhan-Lian Huang, et al.
Gastroenterology Report|September 27, 2021
The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patientsWen-Xiong Xu, Yang-Mei Li, Jian-Guo Li, et al.
Pageof 3